ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

CFRX ContraFect Corporation

0.2318
0.00 (0.00%)
02 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
ContraFect Corporation CFRX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 0.2318 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.2318 0.2318
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
14/2/202413:24EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/11/202315:41EDGAR2Form 8-K - Current report
08/11/202315:30EDGAR2Form 8-K - Current report
03/11/202316:08EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02/11/202323:16EDGAR2Form EFFECT - Notice of Effectiveness
30/10/202316:24EDGAR2Form S-1 - General form for registration of securities under..
24/10/202315:06EDGAR2Form S-1 - General form for registration of securities under..
23/10/202315:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
16/10/202306:30GLOBEContraFect Announces FDA Clearance of CF-370 IND Application..
29/9/202310:15EDGAR2Form 8-K - Current report
25/9/202307:00EDGAR2Form DEF 14A - Other definitive proxy statements
19/9/202307:30GLOBEContraFect to Present at the ASM/ESCMID Joint Conference on..
18/9/202306:30GLOBEContraFect Announces Submission of IND Application to the..
14/9/202315:05EDGAR2Form PRE 14A - Other preliminary proxy statements
28/8/202307:00GLOBEContraFect to Present at the World Anti-Microbial Resistance..
18/8/202316:10EDGAR2Form 8-K - Current report
14/8/202315:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202315:10EDGAR2Form 8-K - Current report
14/8/202307:30GLOBEContraFect Reports Second Quarter 2023 Financial Results and..
25/7/202315:33EDGAR2Form 8-K - Current report
27/6/202307:30GLOBEContraFect Enters Into a Warrant Exercise Transaction for..
20/6/202307:59GLOBEContraFect Data Presentations at ASM Microbe 2023..
08/6/202315:01GLOBEContraFect to Present New Data Demonstrating the Potential..
15/5/202307:00GLOBEContraFect Reports First Quarter 2023 Financial Results and..

Su Consulta Reciente

Delayed Upgrade Clock